Alzamend Neuro annual free cash flow
2022
2024
2025
Alzamend Neuro Free Cash Flow (FCF) History (ALZN)
Alzamend Neuro reported −$6.9M in free cash flow for fiscal 2025, an increase of $1.5M from the previous fiscal year.
View full Alzamend Neuro company overviewAlzamend Neuro free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-04-30 | −$6.9M | $1.5M | — | — |
| 2024 | 2024-04-30 | −$8.4M | −$1.7M | — | — |
| 2022 | 2022-04-30 | −$6.7M | — | — | — |
Alzamend Neuro quarterly free cash flow
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2025 | 2025-04-30 | −$898,705 | $528,002 | — | — |
| Q3 2025 | 2025-01-31 | −$1.4M | $608,024 | — | — |
| Q2 2025 | 2024-10-31 | −$3.4M | −$1.9M | — | — |
| Q1 2025 | 2024-07-31 | −$1.1M | $2.3M | — | — |
| Q4 2024 | 2024-04-30 | −$1.4M | — | — | — |
| Q3 2024 | 2024-01-31 | −$2.0M | — | — | — |
| Q2 2024 | 2023-10-31 | −$1.5M | — | — | — |
| Q1 2024 | 2023-07-31 | −$3.4M | — | — | — |
Alzamend Neuro free cash flow growth trends
Alzamend Neuro's latest reported quarter, Q4 2025, generated −$898,705 in free cash flow, an increase of $528,002 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Alzamend Neuro filings at SEC.gov ↗